Predicted protein targets (top 20)
| gene | UniProt | supporting neighbours | confidence | |
|---|---|---|---|---|
| ▸ | KDM4E | B2RXH2 | 3/20 | 0.53 |
| ▸ | HSD17B10 | Q99714 | 2/20 | 0.53 |
| ▸ | CYP1A2 | P05177 | 1/20 | 0.53 |
| ▸ | GLA | P06280 | 1/20 | 0.53 |
| ▸ | CYP2C9 | P11712 | 1/20 | 0.53 |
| ▸ | HPGD | P15428 | 1/20 | 0.53 |
| ▸ | CYP2C19 | P33261 | 1/20 | 0.53 |
| ▸ | SIRT1 | Q96EB6 | 1/20 | 0.53 |
| ▸ | MAPT | P10636 | 2/20 | 0.50 |
| ▸ | ACHE | P22303 | 2/20 | 0.44 |
| ▸ | MTNR1A | P48039 | 1/20 | 0.42 |
| ▸ | MTNR1B | P49286 | 1/20 | 0.42 |
| ▸ | SMPD1 | P17405 | 1/20 | 0.41 |
| ▸ | VDR | P11473 | 1/20 | 0.40 |
| ▸ | TDP1 | Q9NUW8 | 2/20 | 0.39 |
| ▸ | ALDH1A1 | P00352 | 1/20 | 0.39 |
| ▸ | CYP2A6 | P11509 | 1/20 | 0.39 |
| ▸ | TSHR | P16473 | 1/20 | 0.39 |
| ▸ | NPC1 | O15118 | 1/20 | 0.39 |
| ▸ | LMNA | P02545 | 1/20 | 0.39 |
Click a target to see other patent compounds predicted against it — the reverse direction, in place.
Similar compounds — the chemically nearest patent molecules
Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.
| Compound | similarity | top predicted | shared targets | |
|---|---|---|---|---|
| SCHEMBL30003445 | 1.00 | KDM4E (0.53) | KDM4EHSD17B10CYP1A2GLACYP2C9 | |
| SCHEMBL29670013 | 1.00 | KDM4E (0.53) | KDM4EHSD17B10CYP1A2GLACYP2C9 | |
| SCHEMBL30505176 | 0.91 | HPRT1 (0.47) | KDM4EHSD17B10CYP1A2GLACYP2C9 | |
| SCHEMBL372146 | 0.91 | HPRT1 (0.47) | KDM4EHSD17B10CYP1A2GLACYP2C9 | |
| SCHEMBL7473565 | 0.89 | KDM4E (0.56) | KDM4EHSD17B10CYP1A2GLACYP2C9 | |
| SCHEMBL30830197 | 0.89 | KDM4E (0.56) | KDM4EHSD17B10CYP1A2GLACYP2C9 | |
| Water SCHEMBL16634424 | 0.87 | KDM4E (0.54) | KDM4EHSD17B10CYP1A2GLACYP2C9 | |
| SCHEMBL29269339 | 0.80 | HPRT1 (0.50) | KDM4EHSD17B10CYP1A2GLACYP2C9 | |
| Acetic Acid SCHEMBL11711913 | 0.78 | KDM4E (0.50) | KDM4EHSD17B10CYP1A2GLACYP2C9 | |
| SCHEMBL1143507 | 0.77 | HTR2C (0.45) | ACHEMTNR1AMTNR1B |
Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.
Patent provenance — the patents this molecule appears in, and who filed them
Claimed or disclosed in 175 patents — showing the first 20. claimed = in the patent's claims; disclosed = body only.
| Patent | Title | Assignee | Published | Priority | Filing | Country | Status |
|---|---|---|---|---|---|---|---|
| CN-117580837-A | Compound and organic light emitting device comprising the same | 株式会社LG化学 | 2024-02-20 | — | — | CN | claimed |
| CN-117479566-A | Composition, light emitting device including the same, and electronic device including the light emitting device | 三星电子株式会社 | 2024-01-30 | — | — | CN | claimed |
| CN-117479565-A | Light emitting device and electronic apparatus including the same | 三星电子株式会社 | 2024-01-30 | — | — | CN | claimed |
| US-10562275-B2 | Glass pane as head-up display | SEKISUI CHEMICAL CO., LTD. (JP) | 2020-02-18 | — | — | US | claimed |
| US-9855727-B2 | Glass pane as head-up display | SEKISUI CHEMICAL CO., LTD. (JP) | 2018-01-02 | — | — | US | claimed |
| US-9816027-B2 | Method for producing a film having luminescent particles | SEKISUI CHEMICAL CO., LTD. (JP) | 2017-11-14 | — | — | US | claimed |
| US-20170184845-A1 | GLASS PANE AS HEAD-UP DISPLAY | SEKISUI CHEMICAL CO., LTD. (JP) | 2017-06-29 | — | — | US | claimed |
| EP-2595808-B1 | LAMINATED GLAZING USED AS HEAD-UP-DISPLAY | SAINT GOBAIN (FR) | 2017-04-05 | — | — | EP | claimed |
| EP-2697336-B1 | PROCESS FOR THE MANUFACTURE OF A FILM WITH LUMINOUS PARTICLES | SAINT GOBAIN (FR) | 2016-06-01 | — | — | EP | claimed |
| US-9314998-B2 | Composite glass pane as a head-up display | SAINT-GOBAIN GLASS FRANCE (FR) | 2016-04-19 | — | — | US | claimed |
| EP-1410785-B1 | Make-up product, combining two compositions, comprising a photochromic dye and a goniochromatic agent, respectively | OREAL (FR) | 2007-01-03 | — | — | EP | claimed |
| US-20040228817-A1 | Makeup combining at least one photochromic dye and at least one goniochromatic agent | L'OREAL (FR) | 2004-11-18 | — | — | US | claimed |
| US-20040228818-A1 | Cosmetic composition combining at least two dyes including at least one photochromic dye | L'OREAL (FR) | 2004-11-18 | — | — | US | claimed |
| EP-0755527-B1 | PHOTOCHROMIC NAPHTHOPYRAN COMPOUNDS | PPG IND OHIO INC (US) | 2000-03-15 | — | — | EP | claimed |
| EP-0755527-A4 | PHOTOCHROMIC NAPHTHOPYRAN COMPOUNDS | PPG INDUSTRIES INC (US) | 1997-06-18 | — | — | EP | claimed |
| EP-0755527-A1 | PHOTOCHROMIC NAPHTHOPYRAN COMPOUNDS | PPG INDUSTRIES, INC. (US) | 1997-01-29 | — | — | EP | claimed |
| US-5565147-A | OPHTHALMIC LENSES | TRANSITIONS OPTICAL, INC. (US) | 1996-10-15 | — | — | US | claimed |
| WO-1995027914-A1 | PHOTOCHROMIC NAPHTHOPYRAN COMPOUNDS | PPG INDUSTRIES, INC. (US) | 1995-10-19 | — | — | WO | claimed |
| US-5451344-A | Opthalmic lenses or transparencies for photochromic compounds | TRANSITIONS OPTICAL, INC. (US) | 1995-09-19 | — | — | US | claimed |
| US-5429774-A | FOR USE IN PHOTOCHROMIC ARTICLES | TRANSITIONS OPTICAL, INC. (US) | 1995-07-04 | — | — | US | claimed |
Patent text — is the patent's own abstract consistent with the prediction?
For each of this compound's patents that has machine-readable text (2 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.
| Patent | Title | Text reads most about | Predicted target · text-rank |
|---|---|---|---|
| US-20040228817-A1 | Makeup combining at least one photochromic dye and at least one goniochromatic agent | GYPA, TYR, GLA | KDM4E 4265/4885HSD17B10 358/4885CYP1A2 611/4885 |
| US-20040228818-A1 | Cosmetic composition combining at least two dyes including at least one photochromic dye | CUTA, TYR, LAGE3 | KDM4E 3484/4885HSD17B10 776/4885CYP1A2 2600/4885 |
“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.